STAT June 2, 2020
The Covid-19 pandemic has upended the normal ways of doing everything from going to school to making sure countries have the medications their citizens need. It has also exposed vulnerabilities in the global medicine supply chain, leading to uncertainty, drug shortages, quality issues, and price volatility.
Strengthening the supply chain to ensure an uninterrupted supply of essential medicines that are safe, meet standards for quality, and are beneficial to health — something the U.S. Senate’s Finance Committee will be discussing at a hearing Tuesday afternoon — should be seen as a public health priority.
The dependence of Americans on medicines and their active ingredients mostly made in a handful of countries outside the U.S. raises concerns about supply-chain disruptions and...
Today's Sponsors
Today's Sponsor